期刊文献+

特应性皮炎发病机制与治疗研究进展 被引量:9

Research Progress on Pathogenesis and treatment of atopic dermatitis
在线阅读 下载PDF
导出
摘要 近年来随着环境污染的加剧,特应性皮炎(AD)的临床发病率呈逐年上升趋势,全球关于特应性皮炎的发病机理与治疗手段研究有了新的认识和突破。通过对近年来特应性皮炎发病机理与治疗手段的新进展进行综述,发现遗传、皮肤屏障功能失常、免疫和感染等多种因素参与了特应性皮炎病理发生的过程,外用药物、湿敷、润肤剂和口服药物等是特应性皮炎的主要治疗方法,并且大胆推测未来针对特应性皮炎的研究可能从饮食和环境改变来预防该疾病的发生和控制病情的发展。 With the aggravation of environmental pollution, the incidence rate of atopic dermatitis(AD) has been increasing year by year.In recent years, the global pathogenesis and treatment of atopic dermatitis has gradually gained new understanding and new breakthrough.This paper reviews the new progress in the pathogenesis and treatment of atopic dermatitis(AD) in the last few years.It is found that many factors such as heredity, abnormal skin barrier function, immunity and infection are involved in the pathological process of atopic dermatitis.Topical drugs, wet compress, emollients and oral drugs are the main treatment methods of atopic dermatitis, It is boldly speculated that future research on atopic dermatitis(AD) may prevent the occurrence and control the development of the disease from dietary and environmental changes.
作者 李云卿 Li Yunqing(Anhui Institute of sports technology,Hefei City,Anhui Province 230051)
出处 《黄河科技学院学报》 2022年第2期51-55,共5页 Journal of Huanghe S&T College
关键词 特应性皮炎 发病机制 治疗 进展 atopic dermatitis pathogenesis treatment progress
作者简介 李云卿(1983-),男,安徽安庆人,副教授,硕士,从事运动性疾病的研究。
  • 相关文献

参考文献5

二级参考文献94

  • 1林颖,陈达灿,莫秀梅.特应性皮炎中医证候分类现状与辨证施治疗效的评价[J].中国中西医结合皮肤性病学杂志,2005,4(4):266-271. 被引量:23
  • 2郎娜,姚春海,柏燕军,迟慧彦,佘远遥,黄尧洲.参归煎剂合湿毒膏治疗血虚风燥型特应性皮炎[J].中国中西医结合皮肤性病学杂志,2007,6(1):22-23. 被引量:6
  • 3殷红,黄越燕,蒋小红,王嘉.杭白菊挥发油的抗菌抗炎作用及对PGE_2的影响[J].浙江预防医学,2007,19(8):8-9. 被引量:35
  • 4Irvine AD. Fleshing out filaggrin phenotypes. J Invest Dermatol 2007;127:504-7. doi: 10.1038/sj.jid.5700695.
  • 5Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007; 120: 150-5. doi: 10.1016/j.jaci.2007.04.031.
  • 6Tintle S, Shemer A, Suarez-Farinas M, Fujita H, Gilleaudeau P, Sullivan-Whalen M, et al. Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response. J Allergy Clin Immunol 2011;128:583-93.el-4. doi: 10.1016/j.jaci.2011.05.042.
  • 7Zhang H, Guo Y, Wang W, Shi M, Chen X, Yao Z. Mutations in the filaggrin gene in Han Chinese patients with atopic dermatitis. Allergy 2011;66:420-7. doi: 10.1111/j.1398-9995.2010.02493.x.
  • 8Ma L, Zhang L, Di ZH, Zhao LP, Lu YN, Xu J, et al. Association analysis offilaggrin gene mutations and atopic dermatitis in Northern China. Br J DermatoI2010;162:225-7. doi: 10.l11llj.1365-2133.200 9.09539.x.
  • 9Barker IN, Palmer CN, Zhao Y, Liao H, Hull PR, Lee SP, et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset alopic dermatitis that persists into adulthood. J Invest DermatoI2007;127:564-7. doi: 10.1038/sj.jid.5700587c.
  • 10Howell MD, Fairchild HR, Kim BE, Bin L, Boguniewicz M, Redzic JS, et al. Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol 2008; 128:2248-58. doi: 10.1038/jid.2008.74/.

共引文献51

同被引文献117

引证文献9

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部